NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00948961 2016-06-27A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Celldex TherapeuticsPhase 1/2 Completed70 enrolled